NSE · NEPHROPLUS

Nephrocare Health Services Limited

Sector: Healthcare · ISIN: INE428V01029

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#713

of 5,072 stocks

▼ 281W

Peak #685 · 21 Sep 2026

Nephrocare Health Services Limited is a midcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 64%. Ownership as of Jun 2026.

Market Cap

6,990.19 Cr

P/E Ratio

82.15

P/B Ratio

6.26

ROE

6.88%

ROCE

13.73%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	281.75 Cr	265.62 Cr	259.73 Cr	243.71 Cr
Net Profit	31.97 Cr	30.37 Cr	32.24 Cr	-9.48 Cr
EPS	3.19	3.03	3.43	—
Operating Profit	46.80 Cr	39.49 Cr	42.32 Cr	41.89 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

63.85%

Public

36.15%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

₹197.74

Cr total

Schemes

Fund Houses

₹197.74 Cr

Total Exposure

SBI Mutual Fund₹95.09 Cr (48.1%)

DSP Mutual Fund₹43.37 Cr (21.9%)

Baroda BNP Paribas Mutual Fund₹22.13 Cr (11.2%)

Helios Mutual Fund₹17.68 Cr (8.9%)

ICICI Prudential Mutual Fund₹12.95 Cr (6.6%)

Others₹6.51 Cr (3.3%)

Scheme	Fund House	Value (Cr)	%

All MF holders by market value as of 01 Aug 2026.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs